user

SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE plus CARBOPLATIN FOLLOWED BY GEMCITABINE plus CARBOPLATIN plus DOCETAXEL FOR ADVANCED UPPER-TRACT UROTHELIAL CANCER

被引：0
|
作者：
Yoneyama, Takahiro
Ishibashi, Yuusuke
Okamoto, Teppei
Suzuki, Yuuichirou
Tobisawa, Yuuki
Yoneyama, Toru
Okamoto, Akiko
Yamamoto, Hayato
Imai, Atsushi
Hatakeyama, Shingo
Mori, Kazuyuki
Hashimoto, Yasuhiro
Koie, Takuya
Kamimura, Noritaka
Ohyama, Chikara
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.608
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
535
引用
收藏
页码：E220 / E220
页数：1
相关论文
共 50 条
  • [31] Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?
    Jacobs, Andrew
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08): : 424 - 425
  • [32] Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?
    Andrew Jacobs
    Nature Clinical Practice Oncology, 2006, 3 : 424 - 425
  • [33] Sequential therapy with gemcitabine and carboplatin followed by paclitaxel in first line treatment of advanced urothelial cancer
    Farhat, F. S.
    Boutros, C.
    Kattan, J. G.
    Chahine, G.
    Younes, F.
    Ghosn, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
    Ohyama, Chikara
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 3 - 4
  • [35] Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer
    Kattan, Joseph G.
    Boutros, Celine Y.
    Farhat, Fadi S.
    Chahine, Georges Y.
    Musallam, Khaled M.
    Ghosn, Marwan G.
    JOURNAL OF CANCER, 2012, 3 : 362 - 368
  • [36] Correlation of tumor response and survival in advanced NSCLC patients treated with paclitaxel plus carboplatin (PC) versus paclitaxel plus carboplatin plus gemcitabine (PCG)
    Paccagnella, A.
    Oniga, F.
    Bearz, A.
    Favaretto, A.
    Barbieri, F.
    Chella, A.
    Ceresoli, G.
    Biason, R.
    D'Amanzo, P.
    Ghi, M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Correlation of tumor response and survival in advanced NSCLC patients treated with paclitaxel plus carboplatin (PC) vs paclitaxel plus carboplatin plus gemcitabine (PCG)
    Paccagnella, Adriano
    Oniga, Francesco
    Bearz, Alessandra
    Favaretto, Adolfo
    Barbieri, Fausto
    Chella, Antonio
    Ceresoli, Giovanni
    Biason, Rita
    D'Amanzo, Paola
    Ghi, Maria Grazia
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S315 - S316
  • [38] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [39] Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function
    Galsky, Matthew D.
    Iasonos, Alexia
    Mironov, Svetlana
    Scattergood, Joseph
    Boyle, Mary G.
    Bajorin, Dean F.
    CANCER, 2007, 109 (03) : 549 - 555
  • [40] Gemcitabine plus carboplatin in recurrent and advanced breast cancer: A phase II trial.
    Silva, JA
    Michel, LMP
    Rincon, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 95S - 95S
12345